450 related articles for article (PubMed ID: 22836056)
21. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
[TBL] [Abstract][Full Text] [Related]
22. Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy.
Gensheimer MF; Hummel-Kramer SM; Cain D; Quang TS
Med Dosim; 2015; 40(3):232-4. PubMed ID: 25704638
[TBL] [Abstract][Full Text] [Related]
23. A model for predicting the dose to the parotid glands based on their relative overlapping with planning target volumes during helical radiotherapy.
Millunchick CH; Zhen H; Redler G; Liao Y; Turian JV
J Appl Clin Med Phys; 2018 Mar; 19(2):48-53. PubMed ID: 29105949
[TBL] [Abstract][Full Text] [Related]
24. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
[TBL] [Abstract][Full Text] [Related]
25. Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose-response relationship of parotid-sparing radiotherapy in head-neck cancers.
Gupta T; Hotwani C; Kannan S; Master Z; Rangarajan V; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
Radiat Oncol; 2015 Mar; 10():67. PubMed ID: 25889705
[TBL] [Abstract][Full Text] [Related]
26. Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.
Miah AB; Gulliford SL; Morden J; Newbold KL; Bhide SA; Zaidi SH; Hall E; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e69-e76. PubMed ID: 26994893
[TBL] [Abstract][Full Text] [Related]
27. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.
Cannon DM; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):660-5. PubMed ID: 18037580
[TBL] [Abstract][Full Text] [Related]
28. Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.
Stromberger C; Cozzi L; Budach V; Fogliata A; Ghadjar P; Wlodarczyk W; Jamil B; Raguse JD; Böttcher A; Marnitz S
Strahlenther Onkol; 2016 Apr; 192(4):232-9. PubMed ID: 26852243
[TBL] [Abstract][Full Text] [Related]
29. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.
Roesink JM; Moerland MA; Hoekstra A; Van Rijk PP; Terhaard CH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1451-60. PubMed ID: 15050323
[TBL] [Abstract][Full Text] [Related]
30. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
[TBL] [Abstract][Full Text] [Related]
31. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
[TBL] [Abstract][Full Text] [Related]
32. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
[TBL] [Abstract][Full Text] [Related]
34. The Capabilities and Characteristics of Helical Tomotherapy and Co-Planar Dual Arcs Volumetric-Modulated arc Therapy Associated with Hippocampal Sparing During Prophylactic Cranial Irradiation.
Wang D; Ma X; Fu L; Gu J; Bai T; Yin Y; Li B; Zhu J
Technol Cancer Res Treat; 2021; 20():15330338211043975. PubMed ID: 34632869
[No Abstract] [Full Text] [Related]
35. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
[TBL] [Abstract][Full Text] [Related]
36. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
Cheng JC; Chao KS; Low D
Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer.
Nguyen NP; Vos P; Vinh-Hung V; Ceizyk M; Smith-Raymond L; Stevie M; Slane B; Chi A; Desai A; Krafft SP; Jang S; Hamilton R; Karlsson U; Abraham D
BMC Cancer; 2012 May; 12():175. PubMed ID: 22578076
[TBL] [Abstract][Full Text] [Related]
38. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results.
Ship JA; Eisbruch A; D'Hondt E; Jones RE
J Dent Res; 1997 Mar; 76(3):807-13. PubMed ID: 9109831
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.
Chao KS; Low DA; Perez CA; Purdy JA
Int J Cancer; 2000 Apr; 90(2):92-103. PubMed ID: 10814959
[TBL] [Abstract][Full Text] [Related]
40. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]